Determinants of mortality in non-neutropenic ICU patients with candidaemia
about
Central venous catheter (CVC) removal for patients of all ages with candidaemiaWhat was old is new again: using the host response to diagnose infectious disease.Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT studyCandida glabrata persistence in mice does not depend on host immunosuppression and is unaffected by fungal amino acid auxotrophy.Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal SepsisCandidemia in patients with prolonged fever in Kashan, Iran.Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year periodResistance to antifungals that target CYP51.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Invasive candidiasis in non-hematological patients.Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patientsSynergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species.Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia.The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia.Year in review 2009: Critical Care--infection.Design and use of Candida scores at the intensive care unit.Occurrence, presentation and treatment of candidemia.Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation.Effect of usnic acid on Candida orthopsilosis and C. parapsilosis.Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis.Candida glabrata candidemia: An emerging threat in critically ill patients.Invasive Candida infections in patients of a medical intensive care unit: attempt of improving diagnosis by quantifying the colonization.Management of invasive candidiasis in the intensive care unit.Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.Invasive candidiasis in intensive care units in China: a multicentre prospective observational study.Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC)Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis
P2860
Q26471135-98AB474E-9C0F-4F51-800B-94B112333437Q30376327-C8D990A7-069E-4853-80EF-ABE736BBE29CQ31054881-FB5863B7-053C-434A-AA1E-61D7705C009AQ33675986-9242CB72-3B9E-49E8-A652-F9E16F3FC7D0Q33719218-E740BA5A-6354-478A-B13B-E60A5118769EQ33735943-4DF593E1-8B45-48C8-B9EA-2EFC82188042Q33851292-127F70B3-1601-49F8-A178-78E5B8D91F4AQ34252030-070B306E-482B-4024-A43C-8B0352215849Q34276700-F9BCB780-4594-471D-87F4-37CA04B8C698Q34505582-4CA00ADD-10F8-4090-A9DA-093D8EAA77A3Q35010671-22CECC16-457F-4E0C-A4A5-260041240945Q35028914-EB70CA9A-C654-473A-8B5F-6E820065FCECQ35105804-EE20ADE0-077B-41D1-AF93-00684DE3B1A3Q35192301-BBA0E603-016E-4976-86AD-9576CB78DB4EQ37003676-06347179-9238-4296-A87C-4022C8707EC1Q37814492-B8CB6426-7D5E-414C-8B8F-653A66189C86Q37871069-E937489D-C4ED-4012-9C97-4CD2ADC2EC78Q38061190-C008F6C6-61E8-4B6D-A893-7EC35E2252D9Q40064399-E695FBEA-5A14-456F-8356-326F8032D7BFQ40325883-266BF2AA-B9F5-405F-BA45-9A45492CF192Q40522242-8D245061-94E3-4F22-9D41-2E5B0BA36D83Q41382420-124A8324-EE39-48C0-9BB8-5A744BB5B1C6Q41654518-41821251-C14C-4FF1-A153-E821422D8C5EQ43082447-68CC48BC-CBAB-4A28-B366-3666ED154365Q44612152-8FAAE575-F1B2-4642-89C6-FB01FB3EC369Q44732207-E51C449C-96E7-4006-BAE1-E09126E7284AQ44830700-688D733F-D0C5-4B73-8330-E8339BFF4E9FQ57746129-9AEFEC45-5FDC-4559-9597-6BBF46D10523Q57746135-F8320ECF-63D3-4B09-8919-1649DE0C51AF
P2860
Determinants of mortality in non-neutropenic ICU patients with candidaemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Determinants of mortality in non-neutropenic ICU patients with candidaemia
@en
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
@nl
type
label
Determinants of mortality in non-neutropenic ICU patients with candidaemia
@en
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
@nl
prefLabel
Determinants of mortality in non-neutropenic ICU patients with candidaemia
@en
Determinants of mortality in non-neutropenic ICU patients with candidaemia.
@nl
P2093
P2860
P356
P1433
P1476
Determinants of mortality in non-neutropenic ICU patients with candidaemia
@en
P2093
Australian Candidaemia Study
David Ellis
Deborah J E Marriott
E Geoffrey Playford
Quoc Nguyen
Sharon Chen
P2860
P2888
P356
10.1186/CC7964
P577
2009-07-13T00:00:00Z
P5875
P6179
1020678115